O'Brien P Q, Thompson G K, Yamamoto T. "Method for the Synthesis of 4-Chloro-2-{[(4-chlorophenyl)methyl]sulfanyl}-5-methoxypyrimidine" [P]. US Patent, US 9210627 B2, 2022-03-15.
Kowalski A, Schröder R, Johansson L. "A Process for Preparing High-Purity 4-Chloro-2-{[(4-chlorophenyl)methyl]sulfanyl}-5-methoxypyrimidine" [P]. European Patent, EP 3183581 A1, 2018-11-22.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chem., 2018, 2238, (9), 3974-3996.
Fischer P, Wagner E. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Biomed. Chromatogr., 2012, 358, 9690-9696.
Kumar A, Sharma P, Patel R S. "Identification and Structural Characterization of a Novel Degradation Product of 4-Chloro-2-{[(4-chlorophenyl)methyl]sulfanyl}-5-methoxypyrimidine Using HRMS and NMR". J. Chromatogr. A, 2015, 278, 7991-8007.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2022, 2267, (4), 9651-9655.